Nuvation Bio Inc. (NUVB) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,192
Total Return
-58.08%
CAGR
-15.96%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.45% |
| Median | -1.25% |
| Best | +99.50% |
| Worst | -43.62% |
| % of Windows Positive | 46.7% |
1-Year (252 Trading Days)
| Average | +9.46% |
| Median | -26.09% |
| Best | +257.85% |
| Worst | -82.45% |
| % of Windows Positive | 40.7% |
3-Year (756 Trading Days)
| Average | +12.11% |
| Median | -57.25% |
| Best | +459.52% |
| Worst | -80.32% |
| % of Windows Positive | 32.5% |
Risk Metrics
| Maximum Drawdown | -93.34% |
| Average Drawdown | -71.92% |
| Drawdown Duration | 1224 Trading Days (Unrecovered) |
| Sortino Ratio | 0.21 |
| Calmar Ratio | -0.17 |
| CVaR (5%) | -9.31% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -45.87% (-88.42% ann.) | $4587.05 | $0.00 | $0.00 | $0.00 |
| 2025 | +236.84% | +$23684.17 | $0.00 | $0.00 | $0.00 |
| 2024 | +76.16% | +$7615.92 | $0.00 | $0.00 | $0.00 |
| 2023 | -21.35% | $2135.42 | $0.00 | $0.00 | $0.00 |
| 2022 | -77.41% | $7741.18 | $0.00 | $0.00 | $0.00 |
| 2021 | -27.35% | $2735.04 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +20.62% (+71.45% ann.) | +$2061.86 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | August 26, 2020 – November 6, 2020 | +5.67% | +32.28% | +$567.01 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -13.24% | -12.61% | $1324.24 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -78.60% | -80.54% | $7859.53 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +55.05% | +26.70% | +$5505.04 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +67.24% | +38.79% | +$6724.14 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.